XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Nature of business (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Feb. 28, 2015
Mar. 31, 2017
Cash, cash equivalent, and available-for-sale securities   $ 157.7
Collaborative Arrangement    
Collaborative Arrangement Nonredeemable Up Front Fee Received $ 65.0  
Genzyme    
Net proceeds   $ 278.0
Genzyme | Collaborative Arrangement    
Collaborative Arrangement Nonredeemable Up Front Fee Received $ 65.0  
Genzyme | Redeemable Convertible Preferred Stock Series B | Collaborative Arrangement    
Issuance of stock (in shares) 10,000,000  
Temporary equity issued $ 30.0